Patents by Inventor Anne Borries

Anne Borries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER
    Publication number: 20220042102
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Application
    Filed: August 3, 2021
    Publication date: February 10, 2022
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • MiRNA fingerprint in the diagnosis of multiple sclerosis
    Patent number: 10000810
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: June 19, 2018
    Assignee: Hummingbird Diagnostics GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER
    Publication number: 20180087111
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Application
    Filed: August 8, 2017
    Publication date: March 29, 2018
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA fingerprint in the diagnosis of lung cancer
    Patent number: 9758827
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: September 12, 2017
    Assignee: Comprehensive Biomarker Center GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • MiRNA fingerprint in the diagnosis of prostate cancer
    Patent number: 9745630
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing prostate cancer based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: August 29, 2017
    Assignee: Hummingbird Diagnostics GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA fingerprint in the diagnosis of diseases
    Patent number: 9702008
    Abstract: The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: July 11, 2017
    Assignee: HUMMINGBIRD DIAGNOSTICS GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • miRNA fingerprint in the diagnosis of COPD
    Patent number: 9528158
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: December 27, 2016
    Assignee: Comprehensive Biomarker Center GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF DISEASES
    Publication number: 20160076103
    Abstract: The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: September 28, 2015
    Publication date: March 17, 2016
    Inventors: Andreas KELLER, Eckart MEESE, Anne BORRIES, Peer Friedrich STAEHLER, Markus BEIER
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
    Publication number: 20160053325
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Application
    Filed: October 2, 2015
    Publication date: February 25, 2016
    Applicant: COMPREHENSIVE BIOMARKER CENTER GMBH
    Inventors: Andreas KELLER, Eckart MEESE, Anne BORRIES, Peer Friedrich STAEHLER, Markus BEIER
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20150337393
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing prostate cancer based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g.
    Type: Application
    Filed: August 11, 2015
    Publication date: November 26, 2015
    Applicant: COMPREHENSIVE BIOMARKER CENTER GMBH
    Inventors: Andreas KELLER, Eckart MEESE, Anne BORRIES, Markus BEIER
  • miRNA fingerprint in the diagnosis of diseases
    Patent number: 9194002
    Abstract: The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: November 24, 2015
    Assignee: Comprehensive Biomarker Center GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • miRNA fingerprint in the diagnosis of multiple sclerosis
    Patent number: 9187785
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: November 17, 2015
    Assignee: Comprehensive Biomarker Center GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • miRNA Fingerprint in the Diagnosis of COPD
    Publication number: 20150292020
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: June 30, 2015
    Publication date: October 15, 2015
    Applicant: COMPREHENSIVE BIOMARKER CENTER GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF WILMS' TUMOUR
    Publication number: 20150031777
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: June 23, 2014
    Publication date: January 29, 2015
    Applicant: Comprehensive Biomarker Center GmbH
    Inventors: Andreas KELLER, Eckart MEESE, Anne BORRIES, Markus BEIER
  • MIRNA FINGERPRINT IN THE DIAGNOSIS OF PROSTATE CANCER
    Publication number: 20130053264
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: December 30, 2010
    Publication date: February 28, 2013
    Applicant: FEBIT HOLDING GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF COPD
    Publication number: 20130053263
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: December 30, 2010
    Publication date: February 28, 2013
    Applicant: FEBIT HOLDING GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF WILMS' TUMOUR
    Publication number: 20130035251
    Abstract: MicroRNAs (miRNA) are a recently discovered class of small non-coding RNAs (17-14 nucleotides). Due to their function as regulators of gene expression they play a critical role both in physiological and in pathological processes, such as cancer. The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: December 30, 2010
    Publication date: February 7, 2013
    Applicant: febit holding GmbH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF DISEASES
    Publication number: 20120157336
    Abstract: The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
    Type: Application
    Filed: June 7, 2010
    Publication date: June 21, 2012
    Applicant: FEBIT HOLDING GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • miRNA FINGERPRINT IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS
    Publication number: 20120157337
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miR-NAs that have altered expression levels in disease states compared to healthy controls.
    Type: Application
    Filed: June 7, 2010
    Publication date: June 21, 2012
    Applicant: FEBIT HOLDING GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Peer Friedrich Staehler, Markus Beier
  • MIRNA FINGERPRINT IN THE DIAGNOSIS OF LUNG CANCER
    Publication number: 20120108462
    Abstract: The present invention provides novel methods for diagnosing diseases based on the determination of specific miRNAs that have altered expression levels in disease states compared to healthy controls.
    Type: Application
    Filed: June 7, 2010
    Publication date: May 3, 2012
    Applicant: FEBIT HOLDING GMBH
    Inventors: Andreas Keller, Eckart Meese, Anne Borries, Markus Beier